Infusion Reaction Grading System
Infusion reactions are graded on a 4-point scale (Grade 1-4), with Grades 1-2 representing mild-to-moderate reactions that can be managed with infusion rate adjustments, while Grades 3-4 are severe reactions requiring immediate infusion cessation. 1
Grade-Specific Management Algorithm
The ESMO Clinical Practice Guidelines provide a clear grading framework that directly determines management:
Grade 1 (Mild)
- Action: Slow the infusion rate
- Symptoms are typically mild and self-limiting
- Continue infusion at reduced rate
- No additional medications required beyond standard premedication 1
Grade 2 (Moderate)
- Action: Slow rate or temporarily stop the infusion
- Treatment protocol:
- Administer H1/H2 antagonists: diphenhydramine 50 mg IV plus ranitidine 50 mg IV
- Give corticosteroids equivalent to 1-2 mg/kg IV methylprednisolone every 6 hours
- Restart infusion at 50% of original rate and titrate to tolerance 1
- Most patients (84%) tolerate same-day rechallenge after Grade 2 reactions 2
Grade 3-4 (Severe to Life-Threatening)
- Action: STOP the infusion immediately
- Treatment protocol:
- H1/H2 antagonists: diphenhydramine 50 mg IV plus ranitidine 50 mg IV
- Corticosteroids equivalent to 1-2 mg/kg IV methylprednisolone every 6 hours
- Rechallenge is discouraged in severe reactions 1
- Requires 24-hour observation if severe reaction occurs 1
- Grade 3-4 reactions should prompt allergy specialist referral before any future administration 2
Critical Distinction: Anaphylaxis vs. Cytokine-Release/HSR
The grading system applies specifically to cytokine-release syndrome and hypersensitivity reactions (HSR). If anaphylaxis is suspected (meeting any of three anaphylaxis criteria), this supersedes the grading system and requires:
- Immediate intramuscular epinephrine 0.2-0.5 mg (repeat every 5-15 minutes as needed)
- Aggressive fluid resuscitation
- Full anaphylaxis protocol 1
Real-World Context
Recent data shows that severe (Grade ≥3) infusion reactions occur in approximately 6-28% of patients receiving various immunotherapies 3, 4. The grading system is essential because:
- 90% of reactions occur during the first infusion 4
- Grade 1 reactions can almost always be safely rechallenged same-day 2
- Grade 3 reactions have a high likelihood of recurrence on rechallenge (100% in one series) 2
Common Pitfall
Do not confuse reaction severity with symptom type. Chills are the most common symptom (85% of patients) but are usually Grade 1-2 5. Cardiovascular reactions (particularly hypertension) are the most common manifestation of Grade ≥3 reactions and require close monitoring within the first 4 hours post-infusion 5.